// App-Quantinova.ai

127 : Response to cardiac resynchronisation therapy is associated with reduction in serum parathyroid hormone level

Researchers

Presenter

  • Mark Mills

Principal Investigators

  • Paul Sheridan

  • Patricia Lawford

  • Abdallah Al-Mohammad

  • David Warriner

Medical Centers

  • Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

  • Chesterfield Royal Hospital

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • The University of Sheffield

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • Parathyroid Hormone

Drug/Treatment

  • Parathyroid hormone

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A